JEREMY B. HAYDEN, the Chief Legal Officer of $SGHT, sold 12,733 shares of the company on 07-06-2026 for an estimated $70,133. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.4% of their shares of this class of stock. Following this trade, they now own 357,037 shares of this class of $SGHT stock.
$SGHT Insider Trading Activity
$SGHT insiders have traded $SGHT stock on the open market 27 times in the past 6 months. Of those trades, 0 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $SGHT stock by insiders over the last 6 months:
- PAUL BADAWI (President and CEO) has made 0 purchases and 4 sales selling 92,160 shares for an estimated $500,494.
- ALISON BAUERLEIN (Chief Operating Officer) has made 0 purchases and 5 sales selling 83,329 shares for an estimated $442,201.
- JEREMY B. HAYDEN (Chief Legal Officer) has made 0 purchases and 5 sales selling 43,972 shares for an estimated $247,486.
- DAVID BADAWI (Chief Technology Officer) has made 0 purchases and 5 sales selling 27,168 shares for an estimated $152,794.
- JAMES RODBERG (Chief Financial Officer) has made 0 purchases and 5 sales selling 21,748 shares for an estimated $118,872.
- BRENTON TAYLOR (EVP, Operations & R&D) has made 0 purchases and 3 sales selling 6,317 shares for an estimated $30,578.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SGHT Hedge Fund Activity
We have seen 56 institutional investors add shares of $SGHT stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PATHSTONE HOLDINGS, LLC added 1,678,980 shares (+233.7%) to their portfolio in Q1 2026, for an estimated $6,329,754
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC removed 425,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,602,250
- QUBE RESEARCH & TECHNOLOGIES LTD added 422,822 shares (+566.1%) to their portfolio in Q1 2026, for an estimated $1,594,038
- JACOBS LEVY EQUITY MANAGEMENT, INC added 313,866 shares (+2234.6%) to their portfolio in Q1 2026, for an estimated $1,183,274
- LONG FOCUS CAPITAL MANAGEMENT, LLC added 301,619 shares (+9.2%) to their portfolio in Q1 2026, for an estimated $1,137,103
- SQUAREPOINT OPS LLC added 291,079 shares (+715.6%) to their portfolio in Q1 2026, for an estimated $1,097,367
- WALLEYE CAPITAL LLC removed 280,403 shares (-95.3%) from their portfolio in Q1 2026, for an estimated $1,057,119
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SGHT Revenue
$SGHT had revenues of $19.7M in Q1 2026. This is an increase of 12.51% from the same period in the prior year.
You can track SGHT financials on Quiver Quantitative's SGHT stock page.
You can access data on SGHT stock through the Quiver Quantitative API.
$SGHT Price Targets
Multiple analysts have issued price targets for $SGHT recently. We have seen 3 analysts offer price targets for $SGHT in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $5.15 on 05/28/2026
- Danielle Antalffy from UBS set a target price of $11.0 on 03/06/2026
- Thomas Stephan from Stifel set a target price of $8.0 on 03/02/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
